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Background: Onchocerciasis transmitted by Onchocerca volvulus is the second major cause of blindness in the
world and it impacts negatively on the socio-economic development of the communities affected. Currently,
ivermectin, a microfilaricidal drug is the only drug recommended for treating this disease. There have been
speculations, of late, concerning O. volvulus resistance to ivermectin. Owing to this, it has become imperative to
search for new drugs. World-wide, ethnomedicines including extracts of Euphorbia hirta and Rauvolfia vomitoria are
used for treating various diseases, both infectious and non-infectious.
Method: In this study extracts of the two plants were evaluated in vitro in order to determine their effect against O.
volvulus microfilariae. The toxicity of the E. hirta extracts on monkey kidney cell (LLCMK2) lines was also determined.
Results: The investigations showed that extracts of both plants immobilised microfilariae at different levels in vitro
and, therefore, possess antifilarial properties. It was found that all the E. hirta extracts with the exception of the
hexane extracts were more effective than those of R. vomitoria. Among the extracts of E. hirta the ethyl acetate
fraction was most effective, and comparable to that of dimethanesulphonate salt but higher than that of
Melarsoprol (Mel B). However, the crude ethanolic extract of E. hirta was found to be the least toxic to the LLCMK2
compared to the fractionated forms.
Conclusions: Extracts from both plants possess antifilarial properties; however, the crude extract of E. hirta was
found to be least toxic to LLCMK2.
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Onchocerciasis, transmitted by Onchocerca volvulus is
among the major causes of blindness in the world [1-4]
and has a negative impact on the socio-economic devel-
opment of the communities affected [5-12]. The path-
ology of the disease involves mainly the microfilariae
(mff ) of the parasite. Ivermectin (MectizanW), the drug
recommended for treatment is microfilaricidal only and
has to be administered once within six to 12 months
and continuously for several years [13-18]. Of late, there* Correspondence: skwakuattah@yahoo.com
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reproduction in any medium, provided the orhave been reports of emerging ivermectin resistance in
the adult O. volvulus [19-24]. Should this be confirmed,
the control of the disease will seriously be in jeopardy.
In view of the limited candidate drugs available for test-
ing against the parasite, it has become imperative to
search for new drug(s) preferably a macrofilaricide(s) to
treat the disease.
Presently, one area that is gaining grounds and accept-
ability world-wide is the evaluation and development of
compounds from medicinal plants for the treatment of
diseases. World-wide, ethnomedicines are used for treating
various diseases, both infectious and non-infectious. In
Ghana, a number of plant based products are claimed to
be effective for the treatment of onchocerciasis. Amongtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fia vomitoria reported to have antimicrobial properties
[25-32] are used for this purpose. These have however, not
been subjected to systematic evaluation to ascertain their
effectiveness against O. volvulus. Owing to this, extracts
from these two plants were selected for in vitro evaluation
against the microfilariae (mff) of O. volvulus. The toxicity
of the E. hirta extracts on monkey kidney cell (LLCMK2)
lines was also determined following satisfactory results by
testing its extracts.
Methods
Plant collection, identification and extract preparation
Whole plants of E. hirta and the leaves and roots of R.
vomitoria were collected and identified at the herbarium
of the Botany Department of the University of Ghana in
Accra, Ghana. Voucher specimens of the plants: E. hirta
(GC47751) and R. vomitoria (GC47752) were deposited at
the herbarium. Whole plant specimens of E. hirta and
root specimens of R. vomitoria were air dried for a week
and pulverized into a fine powder. About 300 g of the pul-
verized E. hirta and 270 g of the R. vomitoria materials
were macerated separately in three litres of 80% ethanol.
After 24 hours the slurry of each plant was filtered with
Whatman No.1 filter paper and concentrated under re-
duced pressure in a rotavapor (BUCHI Rotavapor R-114,
Switzerland) at 50°C to recover the ethanol.
A portion of the concentrate was kept as crude ex-
tract. The remaining concentrate was partitioned with
hexane (3 × 250 ml), chloroform (3 × 250 ml) and ethyl
acetate (3 × 250 ml) sequentially (i.e. in an increasing
order of polarity). Each fraction was then concentrated
in vacuo at 50°C with the rotavapor to yield semi-solid
masses. The residual (aqueous) solutions as well as the
crude extracts were freeze-dried. All the extracts were
stored at −20°C until they were used for testing.
Dimethylsulfoxide (DMSO) was used to dissolve the
plant extracts prior to diluting them into stock concen-
trations of 1000 μg/ml in MEM. Prior to testing against
the mff, concentrations ranging from 6.25 to 800 μg/ml
of each of the extracts were prepared from the working
concentration such that the concentration of DMSO in
each of the test solution was less than 0.1%. Melarsoprol
(Mel B) and dimethanesulphonate (DMSPN) salt (Ash
Stevens Inc. Detriot, Michigan 48202) used as reference
drugs (Strote et al., 1990a and b, 1997 and 1998) were
prepared similarly.
For testing against monkey kidney cell lines (LLCMK2)
1:10 serial dilutions of the E. hirta stock solutions were
prepared down to 1 μg/ml. Potassium cyanide (KCN)
(at 1 mg/ml of MEM) solution was used as a positive con-
trol and 1% DMSO in MEM as a solvent (or negative)
control. All the solutions were sterile filtered with a
0.2 μm millipore filter before testing.Selection of Subjects
Twenty-four onchocerciasis subjects between the ages of
18 and 60 from Kpedze-Anoe and Honuta-Gbogame,
who had not taken any antifilarial drugs before were ad-
mitted to the Onchocerciasis Chemotherapy Research
Centre (OCRC) at Hohoe in Ghana after a written
consent had been sought from each of them. The study
was carried out between May 5 and August 25, 2005
following approval from the Ethical Review Board of the
Noguchi Memorial Institute for Medical Research,
University of Ghana.
Harvesting of microfilariae
Skin snips were taken from both iliac crests after steriliz-
ing these sites with 70% alcohol. The snips were placed
in a sterile petri-dish containing five millilitres of Eagle’s
Minimum Essential Medium (MEM) and left on the
bench at 22°C. After three hours of incubation, the snips
were removed, medium transferred into sterile test tubes
and the mff recovered by centrifugation at 1,500 rpm.
Measurement of microfilaricidal action of extracts
One millilitre of each extract and drug preparations was
delivered in triplicates into a 24-well plastic plate. About
30 mff were delivered into each well. The number of mo-
tile mff was determined at 2, 4, 6, 12, 24 and 48 hours of
exposure to the extracts. The same amount of mff was ex-
posed to concentrations between 0.01 and 1.0 per cent of
DMSO (solvent control) and in plain MEM (i.e. without
DMSO, drug or herbal preparation). The assays were car-
ried out in triplicates. Microfilariae were observed under
an inverted microscope and the proportion of motile/live
ones determined.
Inhibition determination of Euphorbia hirta extracts on
monkey kidney cells
Three hundred microlitres of MEM solution contai-
ning about 1000 monkey kidney cells were placed in
each well of 96-well plates. The cells were incubated
at 35°C in a humidified atmosphere of 5% CO2 for a
day. At the beginning of day two the culture medium
was removed from the wells and replaced with 300 μl
of the different diluted extract to give a concentration
of 0–1000 μg/ml and left to incubate for five days.
The same volume of potassium cyanide (KCN) solu-
tion at 1 mg/ml concentration and DMSO in MEM
were each delivered into three wells of the plate. The
cells in three of the wells were killed with hot water
and incubated with plain MEM culture medium
(i.e., without any extract). In three other wells the
cells were maintained with the plain culture medium.
In other experiments, the cells were incubated for
four days before the plant extracts were added and in-
cubated for another two days.
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were removed from the wells and replaced with 300 μl
of tetrazolium salt, 3-(4, 5 dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) solution at
0.5 mg/ml and incubated at 35°C. After 30 minutes the
MTT solution was removed and replaced with 100 μl
DMSO and the plate placed in the dark at a temperature
of 22°C for 1 hour. The formazan produced in each of
the wells was transferred into corresponding wells of
another microtitre plate in duplicates and the optical
density (OD) determined spectrophotometrically at a
wavelength of 510 nm.
Data management and statistical analysis
Data were analyzed using Excel 2000 and Epi-info 6
programme version 6.04d, January 2001. The 50% inhib-
ition concentrations (IC50s) of the extracts were deter-
mined by log probit analysis, and the percentage
inhibitions of the extracts on LLCMK2 were calculated
using the means of the OD values. For comparison of re-
sults the chi-square test was used.
Results
Effect of DMSO on microfilariae
All the mff maintained in the various concentrations of
the solvent control retained their viability up to six
hours of exposure. At 12 hours of exposure, there was a
slight decrease in the number of live/motile mff in the
0.5% concentration (i.e. a decrease of 6.4%) and 1% con-
centration (i.e. a decrease of 1.8%). The mff maintained
their survival above 90% at 24 hours and between 69%
and 76% at 48 hours in all the concentrations. At 48 hours
of exposure about 33% of the mff were immobilised in the
1% DMSO concentration and about 22% in the plain
MEM. No significant difference was found between the
proportions of mff immobilised in these two solutions.
Effect of the plant extracts on microfilariae
The results from the investigations showed that motile
mff were immobilised in various degrees by the E. hirta
and R. vomitoria extracts in a concentration and time
dependent fashion. At 2 hrs of mff exposure more mff
were already immobilised in the 400–800 μg/ml of the
crude extract, 800 μg/ml of the hexane, 400 μg/ml and
800 μg/ml of the chloroform, 25–800 μg/ml of the ethyl
acetate and 400 μg/ml and 800 μg/ml of the aqueous ex-
tracts of the E. hirta plant than the 1% DMSO concen-
tration (p < 0.001). Immobilisation of mff continued in
all the concentrations of the E. hirta extracts (with the
exception of the 6.25 μg/ml and 12.5 μg/ml concentra-
tions of the hexane extracts) and the reference drugs so
much so that by 48 hrs, a significant difference was found
between the proportions of mff that were immobilised in
those concentrations and in the 1% DMSO concentration(p < 0.001). For the R. vomitoria extracts more mff were
found immobilised in the 400 μg/ml and the 800 μg/ml
concentrations than in the 1% DMSO (p < 0.001) from
2 hrs to 24 hrs. Similarly, with the exception of the
6.25 μg/ml of the crude extract and the 6.25-50 μg/ml
of the hexane and ethyl acetate extracts, more mff were
found immobilised in the lower concentrations (6.25-
200 μg/ml) of the extracts of this plant than in the 1%
DMSO concentration at 48 hrs (p < 0.001).
Table 1 shows the percentages of motile O. volvulus
mff found in different concentrations of extracts of the
two plants ranging between 6.25 μg/ml and 200 μg/ml at
2 and 4 hrs. The minimum concentrations of E. hirta
found to have immobilised the mff by 2 hrs of exposure
were: the 12.5 μg/ml concentration of the ethyl acetate,
100 μg/ml of the aqueous, 200 μg/ml of the crude,
400 μg/ml of the chloroform and 800 μg/ml of the hex-
ane extracts. The least concentration that reduced mo-
tile mff numbers to less than 50% among the E. hirta
extracts was the 200 μg/ml concentration of the ethyl
acetate extract. Reduction of live mff below 50% also oc-
curred in the 400 μg/ml of the aqueous extract and in
the crude and chloroform extracts at 800 μg/ml concen-
trations of that plant (Table 2). The various concentra-
tions of the hexane fraction were the least active among
the E. hirta extracts. No significant reduction of mff was
seen in all the concentrations of the R. vomitoria ex-
tracts except in the 800 μg/ml chloroform and the ethyl
acetate extracts (Table 2).
Among the 6.25 μg/ml concentrations of E. hirta im-
mobilisation of mff occurred only in the ethyl acetate ex-
tract at 4 hours, and also occurred in the chloroform
extract at 6 hrs and aqueous extracts at 12 hrs. At 4 hrs
the least concentration of each of the E. hirta extract
that reduced motile mff numbers to less than 50% was
50 μg/ml of the ethyl acetate extract, 200 μg/ml of the
crude extract, the chloroform extract and the aqueous
extract and 800 μg/ml of the hexane extract. At this time
point, the proportion of motile mff had been reduced
significantly to 2% in the 200 μg/ml concentration of the
E. hirta ethyl acetate extract. There was no significant
reduction of motile mff numbers in the concentrations
of R. vomitoria extracts up to 200 μg/ml at this time
point (Table 1).
Table 3 shows the percentage of motile O. volvulus mff
found in concentrations of extracts of the two plants
ranging between 6.25 μg/ml and 200 μg/ml at 6 and
12 hrs. At 6 hours of exposure to concentrations of the
hexane extracts of E. hirta ranging between 6.25 μg/ml
and 200 μg/ml no mff was found immobilised. Immobil-
isation of mff was observed in the 12.5 μg/ml concentra-
tions of the remaining extracts of this plant. The
reduction of motile mff numbers occurred gradually in
the crude, chloroform and aqueous extracts of E. hirta
Table 1 Percentage (± SE) of motile Onchocerca volvulus microfilariae found in 6.25 μg/ml to 200 μg/ml of Euphorbia




6.25 (μg/ml) 12.5 (μg/ml) 25 (μg/ml) 50 (μg/ml) 100 (μg/ml) 200 (μg/ml)
2 hrs 4 hrs 2 hrs 4 hrs 2 hrs 4 hrs 2 hrs 4 hrs 2 hrs 4 hrs 2 hrs 4 hrs
Euphorbia hirta
Crude 100 100 100 97(±3) 100 95(±5) 100 90(±10) 100 55(±29) 73(±24) 36(±32)
Hexane 100 100 100 100 100 100 100 100 100 100 100 100
Chloroform 100 100 100 97(±3) 100 92(±8) 100 69(±22) 100 71(±22) 100 32(±21)
Ethyl acetate 100 98(±2) 98(±2) 96(±2) 64(±28) 54(±27) 55(±29) 46(±23) 54(±29) 38(±28) 35(±19) 2(±2)
Aqueous 100 100 100 100 100 100 100 100 96(±4) 62(±25) 94(±4) 43(±28)
Rauvolfia vomitoria
Crude 100 100 100 100 100 100 100 100 100 100 100 90(±10)
Hexane 100 100 100 100 100 100 100 100 100 100 100 100
Chloroform 100 100 100 100 100 100 100 100 100 100 100 98(±2)
Ethyl acetate 100 100 100 100 100 100 100 100 100 100 100 100
Aqueous 100 100 100 100 100 100 100 100 100 100 100 100
Reference drugs
DMSPN 100 100 100 92(±8) 97(±3) 70(±20) 67(±33) 38(±27) 49(±28) 17(±12) 44(±28) 14(±8)
Mel B 100 100 100 100 100 99(±1) 100 99(±1) 100 99(±1) 94(±6) 81(±11)
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extract of this plant. The minimum concentration that
immobilised more than 90% of the mff at this time point
was the 100 μg/ml of the ethyl acetate, 400 μg/ml of the
chloroform, aqueous and crude extracts and 800 μg/mlTable 2 Percentage (± SE) of motile Onchocerca volvulus micr




400 800 400 800 400 8
2 hrs 4 hrs 6 hrs
Euphorbia hirta
Crude 55(±24) 27(±23) 31(±26) 12(±12) 2(±2) 0
Hexane 100 64(±32) 87(±13) 33(±33) 87(±13) 0
Chloroform 50(±17) 12(±9) 17(±17) 10(±1) 0 0
Ethyl acetate 24(±24) 10(±10) 2(±2) 2(±2) 0 0
Aqueous 46(±27) 32(±21) 28(±18) 24(±24) 2(±2) 0
Rauvolfia vomitoria
Crude 88(±12) 88(±12) 48(±22) 33(±27) 42(±27) 3
Hexane 98(±2) 87(±13) 96(±2) 33(±33) 96(±2) 0
Chloroform 80(±15) 30(±10) 76(±13) 17(±17) 59(±30) 6
Ethyl acetate 100 12(±12) 97(±3) 0 97(±3) 0
Aqueous 100 100 88(±9) 67(±33) 88(±9) 4
Reference drugs
DMSPN 44(±28) 15(±15) 11(±9) 0 0 0
Mel B 88(±5) 3(±3) 65(±11) 0 55(±2) 0
NB: in 1% DMSO 99%, 93.1% and 68% of mff were motile at 12 hrs, 24 and 48 hrs oof the hexane extract (Table 2). No significant difference
was found between the effect of the aqueous extract and
that of the chloroform or the crude extracts. A signifi-
cant difference was however found between the effec-
tiveness of the aqueous extract and that of the hexaneofilariae found in 400 μg/ml and 800 μg/ml of Euphorbia
oncentration(μg/ml)
00 400 800 400 800 400 800
12 hrs 24 hrs 48 hrs
0 0 0 0 0 0
43(±20) 0 4(±4) 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
3(±33) 30(±30) 0 30(±30) 0 22 (±22) 0
70(±18) 0 21(±5) 0 8 (±8) 0
(±6) 56(±28) 0 53(±27) 0 0 0
94(±3) 0 60(±30) 0 7(±7) 0
2(±30) 65(±32) 23(±23) 59(±30) 23(±23) 30 (±30) 0
0 0 0 0 0 0
0 0 0 0 0 0
f exposure respectively.
Table 3 Percentage (± SE) of motile Onchocerca volvulus microfilariae found in 6.25 μg/ml to 200 μg/ml of Euphorbia




6.25 (μg/ml) 12.5 (μg/ml) 25 (μg/ml) 50 (μg/ml) 100 (μg/ml) 200 (μg/ml)
6 hrs 12 hrs 6 hrs 12 hrs 6 hrs 12 hrs 6 hrs 12 hrs 6 hrs 12 hrs 6 hrs 12 hrs
Euphorbia hirta
Crude 100 100 95(±5) 93(±4) 95(±5) 93(±4) 83(±9) 50(±25) 15(±13) 4(±4) 13(±10) 4(±4)
Hexane 100 100 100 100 100 100 100 100 100 85(±1) 100 63(±18)
Chloroform 100 94(±6) 94(±6) 94(±6) 92(±8) 82(±11) 67(±26) 42(±23) 67(±26) 14(±14) 22(±12) 10(±5)
Ethyl acetate 96(±4) 77(±6) 85(±8) 77(±6) 39(±24) 10(±6) 20(±10) 0 2(±2) 0 2(±2) 0
Aqueous 100 83(±10) 97(±3) 82(±10) 85(±11) 50(±26) 73(±18) 50(±26) 47(±27) 18(±10) 29(±29) 8(±8)
Rauvolfia vomitoria
Crude 100 100 100 100 100 100 100 93(±7) 96(±4) 83(±17) 76(±24) 67(±33)
Hexane 100 100 100 100 100 100 100 100 100 100 100 95(±5)
Chloroform 100 100 100 98(±2) 100 98(±2) 100 97(±3) 100 97(±3) 98(±2) 65(±33)
Ethyl acetate 100 100 100 100 100 100 100 100 100 100 100 100
Aqueous 100 96(±4) 100 100 100 100 100 100 100 100 100 91(±6)
Reference drugs
DMSPN 100 84(±16) 64(±18) 55(±23) 38(±26) 19(±16) 33(±24) 10(±10) 11(±9) 10(±10) 5(±5) 5(±5)
Mel B 94(±6) 87(±8) 94(±6) 87(±10) 94(±6) 87(±8) 94(±6) 64(±14) 94(±6) 43(±23) 71(±21) 10(±5)
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tracts, no significant reduction of live mff numbers was
observed except in the 400 μg/ml concentration of the
crude extract and the 800 μg/ml concentration of the
other extracts up to this time point of mff exposure
(Table 2).Table 4 Percentage (± SE) of motile Onchocerca volvulus micr




6.25 (μg/ml) 12.5 (μg/ml) 25 (μg/ml
24 hrs 48 hrs 24 hrs 48 hrs 24 ± hrs 48
Euphorbia hirta
Crude 73(±19) 34(±25) 67 (±21) 34(±25) 67(±21) 25
Hexane 96(±4) 62(±20) 96(±4) 54(±23) 78(±13) 44
Chloroform 77(±12) 33(±33) 63(±23) 33(±33) 63(±22) 25
Ethyl acetate 27(±27) 0 27(±27) 0 0 0
Aqueous 65(±19) 33(±33) 62(±19) 33(±33) 39(±19) 0
Rauvolfia vomitoria
Crude 92(±1) 33(±33) 92(±1) 33(±33) 92(±1) 33
Hexane 89(±11) 33(±33) 89(±11) 33(±33) 80(±1) 33
Chloroform 100 33(±33) 97(±3) 33(±33) 97(±3) 33
Ethyl acetate 100 67(±33) 100 67(±33) 100 63
Aqueous 100 33(±33) 100 33(±33) 100 33
Reference drugs
DMSPN 49(±26) 17(±17) 25(±25) 8(±8) 3(±3) 0
Mel B 22(±22) 17(±17) 22(22) 0 6(±6) 0In the 6.25 μg/ml concentration of the E. hirta ex-
tracts all the mff were motile in the crude and hexane
extracts up to 12 hours of their exposure. At this time
point, no live mff were found in concentrations higher
than 25 μg/ml of the ethyl acetate extract. Live mff
numbers fell below 20% in the 100 μg/ml and 200 μg/mlofilariae found in 6.25 μg/ml to 200 μg/ml of Euphorbia
oncentration(μg/ml)
) 50 (μg/ml) 100 (μg/ml) 200 (μg/ml)
hrs 24 hrs 48 hrs 24 hrs 48 hrs 24 hrs 48 hrs
(±25) 35 (±22) 0 4(±4) 0 4(±4) 0
(±1) 74(±1) 44(±1) 74(±1) 33(±1) 38(±31) 12(±12)
(±25) 20(±20) 0 0 0 0 0
0 0 0 0 0 0
23(±17) 0 10(±5) 0 8(±8) 0
(±33) 87(±13) 33(±33) 71(±29) 33(±33) 67(±33) 33(±33)
(±33) 72(±20) 33(±33) 71(±20) 33(±33) 46(±27) 33(±33)
(±33) 97(±3) 33(±33) 97(±3) 33(±33) 64(±22) 0
(±32) 100 33(±33) 67(±33) 33(±33) 67(±33) 33(±33)
(±33) 79(±18) 33(±33) 78(±22) 33(±33) 59(±30) 30(±30)
3(±3) 0 3(±3) 0 2(±2) 0
6(±6) 0 0 0 0 0
Table 5 Fifty per cent inhibition concentrations (IC50s) of
Euphorbia hirta and Rauvolfia vomitoria extracts on
Onchocerca volvulus microfilariae
Extract/Drug Time of mff exposure (hrs)
2 4 6 12 24 48
IC50s of Euphorbia hirta (μg/ml)
Crude 500 125 75 50 40 <6.25
Hexane >800 700 700 700 150 17.5
Chloroform 400 150 140 50 20 <6.25
Ethyl acetate 100 37.5 21.9 12.5 <6.25 <6.25
Water 400 150 90 25 18.8 <6.25
IC50s of Rauvolfia vomitoria (μg/ml)
Crude >800 400 350 300 300 <6.25
Hexane >800 700 600 450 200 <6.25
Chloroform 650 600 450 400 400 <6.25
Ethyl acetate 650 625 625 625 450 37.5
Water >800 >800 800 400 200 <6.25
IC50s of the reference drugs (μg/ml)
DMSPN 100 40.5 18.8 14.1 6.25 <6.25
Mel B 600 500 400 87.5 <6.25 <6.25
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800 μg/ml concentrations of the crude, chloroform and
aqueous extracts. In the R. vomitoria extracts all the mff
were motile up to 12 hours when they were exposed to
the 6.25 μg/ml concentration. No mff was found
immobilised in the hexane extracts of E. hirta at concen-
trations lower than 400 μg/ml except in the 100 μg/ml
and 200 μg/ml concentrations.
Table 4 shows the percentage of motile mff exposed
to the 6.25 μg/ml to 200 μg/ml concentrations of E.
hirta and R. vomitoria extracts at 24 hrs and 48 hrs
and Table 2 shows the percentage of motile mff ex-
posed to the 400 μg/ml and 800 μg/ml concentrations
of E. hirta and R. vomitoria extracts at 2–24 hrs. At
24 hrs of exposure to the E. hirta extracts the propor-
tion of motile mff were found to have been reduced
drastically. The lowest concentration that killed all the
mff at this time point in the case of the ethyl acetate
extract was 25 μg/ml; chloroform extract, 100 μg/ml
(Table 4) and aqueous extract, 400 μg/ml; hexane ex-
tract, 800 μg/ml and the crude extract, 400 μg/ml
(Table 2). In all the plant extract concentrations, only
in the 800 μg/ml concentration of the aqueous extract
of R. vomitoria were motile mff seen at the same time
point (Table 2). By 48 hrs, all the mff were im-
mobilised in all the concentrations of the ethyl acetate
extract of E. hirta and in the 800 μg/ml concentra-
tions of both the E. hirta and R. vomitoria extracts
(Tables 2 and 4). At this time point, with the E. hirta
plant, motile mff were found in the 6.25 μg/ml and
12.5 μg/ml concentrations of the aqueous extract and
the 6.25 μg/ml to 25 μg/ml concentrations of the
chloroform and crude extracts and 6.25-200 μg/ml of
the hexane extract.
Generally, the extracts of E. hirta were more effec-
tive in immobilising the mff and their IC50s were
lower than those of R. vomitoria. At 2–24 hrs the ex-
tracts of E. hirta were found to be more effective in
immobilising mff than those of R. vomitoria and the
difference was significant (P < 0.004). There was no
significant difference between the ethyl acetate extract
of E. hirta and DMSPN at any time point with regards
to their effectiveness. The various concentrations of
Mel B were less effective in immobilising motile mff
than those of the ethyl acetate extract of E. hirta
(P < 0.019) and those of DMSPN (P < 0.01) at 2–6 hrs
(Tables 1 and 3). Table 5 shows the 50% inhibition
concentrations (IC50s) of the plant extracts and the
reference drugs on O. volvulus mff. The IC50s of all
the extracts and the reference drugs decreased consis-
tently over time. The E. hirta extracts with the excep-
tion of that of the hexane had lower IC50s than those
of R. vomitoria at 24 hrs and Mel B at 12 hrs. Among
the E. hirta extracts that of ethyl acetate had the leastIC50s which were comparable to those of DMSPN up
to 24 hrs. With the exception of the hexane extract of
E. hirta and the ethyl acetate extract of R. vomitoria,
the IC50s of all the extracts as well as DMSPN and
Mel B fell below 6.25 μg/ml at 48 hrs. From the fore-
going, it can be deduced that the E. hirta ethyl acetate
extract (which had the least IC50s) was the most
effective.
Effect of E. hirta extracts on monkey kidney cell lines
Figure 1 shows the effect of E. hirta extracts on the
viability of monkey kidney cells maintained for one
day prior to the exposure of the extracts for five days.
In this figure the crude extracts were seen to exhibit
negative inhibition on the LLCMK2. All the extracts
with the exception of that of chloroform at 1000 μg/ml
concentration also inhibited the cells negatively (i.e. pro-
moted cell proliferation) when they were maintained in
culture for four days before being exposed to the extracts
for two days (Figure 2).
Among these extracts only the crude extract
inhibited the cells in a concentration dependent fash-
ion with the lowest concentration having the highest
effect and vice versa. At each concentration the crude
extract exhibited the lowest inhibition on the cells.
The 1000 μg/ml concentration of the hexane extract
showed the highest inhibition and the 100 μg/ml the
lowest in these two experiments. In the first experi-
































Figure 1 Percentage inhibition of monkey kidney cells lines maintained in culture for one day before exposure to Euphorbia hirta
extracts for 5 days1. 1. Percentage inhibition of potassium cyanide (KCN) at 103 μg/ml = 131%; the optical density (OD) values for: 1% DMSO
(solvent control) = 0.069, cells cultured in plain culture medium = 0.093, and for heat killed cells = −0.015 (negative figures imply promotion of
cell maintenance).
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concentrations of the chloroform, ethyl acetate and
water respectively whilst the 100 μg/ml, 1 μg/ml, and
100 μg/ml concentrations in the same order had the





















Figure 2 Percentage inhibition of monkey kidney cells lines maintain
extracts for two days2. 2. Percentage inhibition of potassium cyanide (KC
(solvent control) = 0.109, cells cultured in plain culture medium = 0.149, and
cell maintenance).experiment the 1000 μg/ml concentration of the chloro-
form and ethyl acetate extract as well as the 1 μg/ml con-
centration of the aqueous extract had the highest whilst
the 100 μg/ml concentrations of the chloroform, ethyl






ed in culture for four days before exposure to Euphorbia hirta
N) at 103 μg/ml = 52.8%; the optical density (OD) values for 1% DMSO
for heat killed cells = −0.037 (negative figures imply promotion of
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Discussion
To date, not much work has been done to investigate the
efficacy of plant extracts against human filarial parasites
except those conducted by Kilian et al. (1990) using
Cassia aubrevillei [33] and Titanji et al. (1990) using
Polyalthia suaveolens [34]. Most of the work conducted so
far involved the use of animal filarial parasites. Some of
the plants used were Acacia auriculiformis [35], Sancio
nudicaulis Buch. Ham. [36], Saxifraga stracheyion root
[37], Centratherum anthelminticum seeds [38], Azadi-
rachta indica and Ficus racemosa Linn. [39,40]. Comley et
al. (1990) reported the macrofilaricidal effects in vitro of
filaricid (a crude extract of the stem bark of Streblus asper,
Lour) and filarin (a crude extract comprising five plants in
different proportions) against Acanthocheilonema viteae
females at 500 μg/ml [41]. They also found that oliverine
derived from n-hexane extract of the stem bark of
Pachypodanthium staudtii has similar effects on the
Acanthocheilonema viteae worm at 120 hours down to
10 μg/ml.
In spite of reports concerning E. hirta and R. vomit-
oria possessing antimicrobial properties, no systematic
studies on their effectiveness against filarial parasites ei-
ther in vivo or in vitro have been carried out. The results
of this study has indicated that extracts of these two
plants possess antifilarial properties. Among the E. hirta
extracts, that of ethyl acetate was most effective, and this
was comparable to that of DMSPN but more effective
than Mel B. The hexane extract of E. hirta and the ex-
tracts of R. vomitoria showed least activity before 48 -
hours of mff exposure. A lot of chemical constituents
including diterpenes, flavonoids, tannins, aromatic acids,
alkaloids, coumarins and anthocyanins, euphorbon,
triterpenes and quercetol have been isolated from every
part of E. hirta [28,29]. The root of R. vomitoria, on the
other hand, contains flavonoids and over 100 alkaloids
including reserpine, rescinnamine, deserpidine, yohim-
bine, aijmaline and alstonine which are therapeutically
important [27-29].
Notwithstanding the efficacy of E. hirta extracts against
these diseases, issues have been raised concerning the tox-
icity of the extracts. For instance, Adedapo et al. (2005) in
conducting in vivo work showed that some chromato-
graphic fractions of the plant have potentially deleterious
effect on the serum chemistry of rats. They therefore cau-
tioned against the use of this plant for medicinal purposes.
Contrary to these findings, Hashemi et al. (2008) observed
a significant decrease in Aspartate transaminase (AST),
Alanine aminotransferase (ALT), and Alkaline phospha-
tase (ALP) after 14 days of oral administration of
2000 mg/kg of the crude aqueous extracts of E. hirta to
chicks [42]. Ogueke et al. (2007) found the crudeethanolic extracts of the plant at concentrations ranging
from 60.4 to 483.0 mg/kg body weight to be
haematologically safe to albino rats. Biochemical analyses
of the renal and hepato-biliary function following oral ad-
ministration of up to 3000 mg/kg body weight of the
crude extracts of the plant were also found to be
haematologically safe and did not show any signs of
nephrotoxicity and hepatotoxicity in rats, as confirmed by
histopathological examination [43].
E. hirta has been used to treat various diseases by
traditional herbal practitioners and its administration
has mainly been through the oral route [25,28-30]. In
this study, the crude extract of E. hirta inhibited cell
growth the least. Moreover, it was the only extract that
was found to have exhibited its effect in a concentration
dependent fashion with the highest concentration having
the least inhibitory effect. This observation is in agree-
ment with that of Brindha et al. (2010) who observed a
dose-dependent increase in viability when antitubercular
drug exposed human liver derived HepG2 cells were
treated with different concentrations of extracts of the
plant [44].
In the current study, when the cells were maintained
for a longer period before being exposed to the extracts,
the survival of the cells was enhanced more than when
they were maintained for a shorter period before their
exposure to the extracts. This observation was most pro-
nounced when the cells were exposed to the crude ex-
tracts. This observation can be explained by the fact that
once the cells form confluence they are inhibited less
than when they have not. A previous investigation by
Raja Sidambaram et al. (2011) using the methanol ex-
tract of the leaves of E. hirta on Hep-‐2 cells from hu-
man epithelioma of the larynx showed a dose dependent
antitumor activity in vitro [45]. The extracts in the
current investigation have also revealed antiproliferative
effects on the cells that have not achieved complete at-
tachment to the plates. This finding shows that extracts
from the plant have the potential to serve as anticancer
agents. The promotion of the vitality of the monkey kid-
ney cells particularly by the crude extract of E. hirta im-
plies that the administration of plant extracts in the
crude form might be safer than the fractionated or puri-
fied forms. This work justifies the use of these plants
particularly in their crude form for treating diseases by
herbal practitioners.
Conclusions
It might be concluded from the foregoing that extracts
of both E. hirta and R. vomitoria possess antifilarial
properties. Of the E. hirta extracts, that of ethyl acetate
was found to be the most effective whilst the crude ex-
tract was the least toxic to monkey kidney cell lines. It is
recommended that further efficacy determination of the
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parasite and further toxicity studies be carried out.
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